United States carrier screening market size is projected to exhibit a growth rate (CAGR) of 14.60% during 2024-2032. The rising focus of healthcare professionals to provide valuable insights of potential genetic risks, which can aid individuals and couples in making informed decisions about family planning, is primarily driving the market growth across the country.
Report Attribute
|
Key Statistics
|
---|---|
Base Year
|
2023 |
Forecast Years
|
2024-2032
|
Historical Years
|
2018-2023
|
Market Growth Rate (2024-2032) | 14.60% |
Carrier screening is a genetic testing method employed to identify abnormal genes in fetuses that may lead to autosomal recessive diseases. This predictive and pre-symptomatic testing approach is utilized by expectant individuals and couples to assess the likelihood of their child inheriting genetic disorders from the parents. The process involves analyzing saliva, blood, or cheek tissue samples to identify the presence of abnormal genes linked to disorders like cystic fibrosis, sickle cell anemia, and Tay-Sachs disease. Molecular and biochemical techniques, such as DNA sequencing, polymerase chain reaction (PCR), and microarray technologies, are employed to screen these samples. Carrier screening encompasses expanded, customized panel, predesigned panel, and targeted disease screening, specifically focusing on pulmonary, hematological, and neurological disorders.
The United States carrier screening market is undergoing dynamic changes driven by key drivers and notable trends, reflecting a commitment to advancing genetic testing and family planning. A primary factor is the growing awareness and emphasis on personalized medicine, prompting an increasing number of individuals and couples to opt for carrier screening to assess their risk of transmitting genetic disorders to their offspring. Additionally, technological advancements are pivotal, with innovations in DNA sequencing, polymerase chain reaction (PCR), and microarray technologies enhancing the accuracy and efficiency of carrier screening. This has led to an expansion of the types of disorders covered and an increased demand for more comprehensive screening panels in the United States. Furthermore, the emerging trend towards expanding screening panels to include a broader range of genetic disorders is gaining momentum across the country. This shift allows for a more holistic approach, covering various pulmonary, hematological, and neurological disorders, providing a more comprehensive understanding of potential genetic risks. Moreover, telehealth solutions have also influenced the United States carrier screening market, facilitating broader accessibility to genetic testing services. These trends highlight the importance of providing individuals and couples with comprehensive genetic information for informed family planning decisions, which is anticipated to fuel the market growth in the country over the forecasted period.
IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the country level for 2024-2032. Our report has categorized the market based on type, medical condition, technology, and end user.
Type Insights:
The report has provided a detailed breakup and analysis of the market based on the type. This includes expanded carrier screening (customized panel testing and predesigned panel testing) and targeted disease carrier screening.
Medical Condition Insights:
A detailed breakup and analysis of the market based on medical condition have also been provided in the report. This includes pulmonary conditions, hematological conditions, neurological conditions, and others.
Technology Insights:
The report has provided a detailed breakup and analysis of the market based on the technology. This includes DNA sequencing, polymerase chain reaction, microarrays, and others.
End User Insights:
A detailed breakup and analysis of the market based on end user have also been provided in the report. This includes hospitals and clinics, reference laboratories, and others.
Regional Insights:
The report has also provided a comprehensive analysis of all the major regional markets, which include Northeast, Midwest, South, and West.
The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.
Report Features | Details |
---|---|
Base Year of the Analysis | 2023 |
Historical Period | 2018-2023 |
Forecast Period | 2024-2032 |
Units | US$ Million |
Scope of the Report | Exploration of Historical and Forecast Trends, Industry Catalysts and Challenges, Segment-Wise Historical and Predictive Market Assessment:
|
Types Covered |
|
Medical Conditions Covered | Pulmonary Conditions, Hematological Conditions, Neurological Conditions, Others |
Technologies Covered | DNA Sequencing, Polymerase Chain Reaction, Microarrays, Others |
End Users Covered | Hospitals and Clinics, Reference Laboratories, Others |
Regions Covered | Northeast, Midwest, South, West |
Customization Scope | 10% Free Customization |
Report Price and Purchase Option | Single User License: US$ 3699 Five User License: US$ 4699 Corporate License: US$ 5699 |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |